Life Sciences Investment Banking

An experienced team in a vibrant sector.

Raymond James Life Sciences practice provides comprehensive advisory and financing capabilities to innovative businesses in the biotechnology, specialty pharmaceutical and generic pharmaceutical sectors. Companies within the biopharma industry continue to face the disruptive forces that require them to tailor their strategies in the continually evolving business environment. Our team provides our clients with solutions based on our deep relationships with company management teams as well as venture, private equity and public market investors.

Life Sciences Subsector Expertise

  • Biotechnology
  • Specialty Pharmaceuticals

Senior Banking Team

Stu Barich
Stuart Barich
Managing Director
New York
   
Read Bio
Dirk-Oliver Loeffler
Dirk-Oliver Loeffler
Managing Director
Frankfurt
   
Read Bio
David Stubbs
Managing Director
San Francisco
   
Read Bio
Bio-no-photo
George Billington
Senior Vice President
New York
   
Deborah Gerewitz
Deborah Gerewitz
Vice President
New York
   
Read Bio
Jens Gerlach
Jens Gerlach
Vice President
Frankfurt
   
Read Bio
Julian Knirim
Julian Knirim
Vice President
Frankfurt
   
Read Bio
Steven Lowry
Vice President
San Francisco
   
Read Bio
Valerie Rinecker
Valerie Rinecker
Vice President
Munich
   
Read Bio

Transaction History

Transaction history may include a transaction completed by a Raymond James banker while at a former firm.

Recent News

Equity Research  |  August 23, 2018
Raymond James analysts received 14 awards in the 2018 Thomson Reuters Analyst Awards

Read More
Investment Banking  |  August 8, 2018
Raymond James Investment Banking Division Creates Diversified Industrials Practice

Read More
Public Finance  |  September 13, 2018
Curtis Culwell joins Raymond James’ Texas K-12 underwriting practice

Read More